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Introduction
Little in the literature is known about the long term
outcome of patients with acute coronary syndrome
(ACS) and in-hospital recurrent ischemic event. Accord-
ingly; our objectives were to determine the baseline
characteristics of patients, the predictors, and the long
term outcome of patients with recurrent ischemia.
Methods
The population compromised 7930 enrolled in the sec-
ond Gulf Registry of Acute Coronary Events (Gulf
RACE-2).
Results
Out of the 7930 ACS patients, 172 (2.2%) had recurrent
myocardial infarction (Re-MI) during their hospital stay.
Patients with Re-MI were more likely to be older (mean
age 59.12±13.5 vs. 56.8±12.4, P=0.016), had significantly
higher rate of prior history of angina (48% vs. 38.2%,
P=0.006), and hyperlipidemia (45.2% vs. 37.3%, P=0.027)
than patients without Re-MI. On admission patients with
Re-MI had significantly higher HR, lower systolic BP,
Killip class 4 and high GRACE risk score than those with-
out Re-MI (27.3% vs. 17.6%), (11% vs. 4.8%), (8.1% vs.
3.2%), and (31.8% vs. 21.5%, P<0.05 for all comparisons)
respectively. Patients with Re-MI had a higher rate of
STEMI on admission than patients without Re-MI (72.1%
vs. 43.9%; P<0.001). Re-MI patients were less likely to
receive Aspirin (94.8% vs. 98.5%, P=0.002), beta- blockers
(95.3% vs. 74.7%, P<0.001), and Statin (87.2% vs. 94.9%,
P<0.001) than patients without Re-MI. Coronary angio-
gram was less frequently performed on patients with
Re-MI than patients without Re-MI (30.8% vs. 32.5%,
P=0.036). In hospital adverse events including HF, cardio-
genic shock, VT/VF were more frequent in the Re-MI
group than patients without Re-MI (44.2% vs. 12.4%),
(25.6% vs. 5.3%), (7.6% vs. 2.7%; P<0.001 for all compari-
sons) respectively. In ACS patients with Re-MI in-hospital,
30 days and 1 year were significantly higher that patients
without Re-MI (23.8% vs. 4.1%), (28.1% vs. 7.7%), and
(31.6% vs. 12.1%; P<0.001 for all comparisons),
respectively.
Conclusions
Recognizing patients at high risk of Re- MI is important as
modifying the risk factors, and managing the patient
aggressively may reduce the incidence of such events and
the associated morbidity and mortality.
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